TRPKO DIMOVSKI: Open Payments
NPI 1205885399 · SHELBY TOWNSHIP, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$554 in 26 payments from 10 companies in 2025. Trend: 2023 $587 · 2024 $1,242 · 2025 $554
Food & beverage: $554
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 6 | $177 |
| Novo Nordisk Inc | 5 | $108 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $64 |
| PFIZER INC. | 3 | $55 |
| Lilly USA, LLC | 3 | $45 |
| ABBVIE INC. | 2 | $43 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $14 |
| Exact Sciences Corporation | 1 | $14 |
| GlaxoSmithKline, LLC. | 1 | $14 |
Products named: Wegovy, CAPLYTA, QULIPTA, OTEZLA, MOUNJARO, PREVNAR 20, XIFAXAN, Ozempic.
Industry payments across MI — which companies pay providers there.
